| Product Code: ETC8563354 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Lipid POCT Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Lipid POCT Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Lipid POCT Market - Industry Life Cycle |
3.4 New Zealand Lipid POCT Market - Porter's Five Forces |
3.5 New Zealand Lipid POCT Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 New Zealand Lipid POCT Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 New Zealand Lipid POCT Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 New Zealand Lipid POCT Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 New Zealand Lipid POCT Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.10 New Zealand Lipid POCT Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 New Zealand Lipid POCT Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Lipid POCT Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lifestyle-related diseases in New Zealand, such as obesity and cardiovascular diseases, driving the demand for lipid POCT (Point of Care Testing) for early detection and management. |
4.2.2 Growing awareness among the population about the importance of regular health screenings and monitoring, leading to higher adoption of lipid POCT devices. |
4.2.3 Advancements in technology leading to the development of innovative and user-friendly lipid POCT devices, making testing more convenient and accessible. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and standards for medical devices in New Zealand, which can increase the time and cost of product approvals and market entry. |
4.3.2 Limited reimbursement policies for lipid POCT testing in New Zealand, impacting the affordability and accessibility of these tests for some segments of the population. |
5 New Zealand Lipid POCT Market Trends |
6 New Zealand Lipid POCT Market, By Types |
6.1 New Zealand Lipid POCT Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Lipid POCT Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 New Zealand Lipid POCT Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 New Zealand Lipid POCT Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 New Zealand Lipid POCT Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 New Zealand Lipid POCT Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Lipid POCT Market Revenues & Volume, By Hyperlipidemia, 2021- 2031F |
6.2.3 New Zealand Lipid POCT Market Revenues & Volume, By Hypertriglyceridemia, 2021- 2031F |
6.2.4 New Zealand Lipid POCT Market Revenues & Volume, By Hyperlipoproteinemia, 2021- 2031F |
6.2.5 New Zealand Lipid POCT Market Revenues & Volume, By Familial hypercholesterolemia, 2021- 2031F |
6.2.6 New Zealand Lipid POCT Market Revenues & Volume, By Tangier Disease, 2021- 2031F |
6.2.7 New Zealand Lipid POCT Market Revenues & Volume, By Others, 2021- 2031F |
6.3 New Zealand Lipid POCT Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Lipid POCT Market Revenues & Volume, By Prescription-Based Testing, 2021- 2031F |
6.3.3 New Zealand Lipid POCT Market Revenues & Volume, By OTC-Based Testing, 2021- 2031F |
6.4 New Zealand Lipid POCT Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Lipid POCT Market Revenues & Volume, By Roche Reflotron, 2021- 2031F |
6.4.3 New Zealand Lipid POCT Market Revenues & Volume, By Roche Cobas B 101, 2021- 2031F |
6.4.4 New Zealand Lipid POCT Market Revenues & Volume, By Alere Cholestech LDX, 2021- 2031F |
6.4.5 New Zealand Lipid POCT Market Revenues & Volume, By Alere Afinion, 2021- 2031F |
6.4.6 New Zealand Lipid POCT Market Revenues & Volume, By Samsung Labgeo, 2021- 2031F |
6.4.7 New Zealand Lipid POCT Market Revenues & Volume, By PTS Cardiochek, 2021- 2031F |
6.5 New Zealand Lipid POCT Market, By Platform |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Lipid POCT Market Revenues & Volume, By Lateral Flow Assays (Immunochromatography Tests), 2021- 2031F |
6.5.3 New Zealand Lipid POCT Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.5.4 New Zealand Lipid POCT Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.5.5 New Zealand Lipid POCT Market Revenues & Volume, By Dipsticks, 2021- 2031F |
6.5.6 New Zealand Lipid POCT Market Revenues & Volume, By Microfluidics, 2021- 2031F |
6.6 New Zealand Lipid POCT Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 New Zealand Lipid POCT Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 New Zealand Lipid POCT Market Revenues & Volume, By Professional Diagnostic Centers, 2021- 2031F |
6.6.4 New Zealand Lipid POCT Market Revenues & Volume, By Home Care, 2021- 2031F |
6.6.5 New Zealand Lipid POCT Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.6.6 New Zealand Lipid POCT Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.7 New Zealand Lipid POCT Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 New Zealand Lipid POCT Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 New Zealand Lipid POCT Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 New Zealand Lipid POCT Market Import-Export Trade Statistics |
7.1 New Zealand Lipid POCT Market Export to Major Countries |
7.2 New Zealand Lipid POCT Market Imports from Major Countries |
8 New Zealand Lipid POCT Market Key Performance Indicators |
8.1 Average turnaround time for lipid POCT results, indicating the efficiency and speed of testing processes. |
8.2 Percentage of healthcare providers offering lipid POCT services, reflecting the penetration and adoption of these devices in the market. |
8.3 Rate of adoption of new lipid POCT technologies, showing the acceptance and demand for advanced testing solutions in New Zealand. |
8.4 Number of partnerships and collaborations between lipid POCT device manufacturers and healthcare facilities, demonstrating the market expansion and distribution network strength. |
9 New Zealand Lipid POCT Market - Opportunity Assessment |
9.1 New Zealand Lipid POCT Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 New Zealand Lipid POCT Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 New Zealand Lipid POCT Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 New Zealand Lipid POCT Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 New Zealand Lipid POCT Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.6 New Zealand Lipid POCT Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 New Zealand Lipid POCT Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Lipid POCT Market - Competitive Landscape |
10.1 New Zealand Lipid POCT Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Lipid POCT Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here